Products

BOLD
2019-07-30
TESTOP
2019-07-30
Show all

NANDRO PH

Details
Potency 100 mg / ml
Appearance oil based solution
Packing 10ml clear glass vials*
Indications Nandrolone phenylpropionate is indicated for treatment of anemia’s, breast carcinoma, hereditary angioedema, antithrombin III deficiency, fibrinogen excess, growth failure and Turner’s syndrome and prophylaxis of hereditary angioedema.

* Supplied in a clear 10 ml glass vials with plastic cap.

* Contains cottonseed oil, refined.

Notes on temperatures the properties:

At cold storage temperatures the properties of this oil-based solution might temporarily change (e.g. higher viscosity, cloudiness). If stored at cold temperature, the product should be brought to room or body temperature before use. The solution for intramuscular injection is to be visually inspected prior to use and only clear solutions free from particles should be used.

Notes on handling the vial:

The vial is for single or multi-use. The content of a vial is to be injected intramuscularly  after drawing up into the syringe and warming up. After removal of the plastic cap (A) do not remove the metal ring (B) or the crimp cap (C).

 

Storage
Store at room temperature, 15° – 30°C (59° – 86°F).
Avoid freezing and cool temperatures below 15°(59°F).

If freezing occurs and crystals are present, contact the manufacturer representative.

 

Description

Nandrolone phenylpropionate (NPP), or nandrolone phenpropionate, sold under the brand name Durabolin among others, is an androgen and anabolic steroid (AAS) medication which has been used primarily in the treatment of breast cancer and osteoporosis in women. It is given by injection into muscle once every week. Although it was widely used in the past, the drug has mostly been discontinued and hence is now mostly no longer available.

Side effects of NPP include symptoms of masculinization like acne, increased hair growth, voice changes, and increased sexual desire. The drug is a synthetic androgen and anabolic steroid and hence is an agonist of the androgen receptor (AR), the biological target of androgens like testosterone and dihydrotestosterone (DHT). It has strong anabolic effects and weak androgenic effects, which give it a mild side effect profile and make it especially suitable for use in women and children. NPP is a nandrolone ester and a long-lasting prodrug of nandrolone in the body.

NPP was first described in 1957 and was introduced for medical use in 1959. It was the first nandrolone ester to be introduced, followed by nandrolone decanoate in 1962, and has been one of the most widely used nandrolone esters. However, in more recent times, the drug has been largely superseded by nandrolone decanoate, which is longer-acting and more convenient to use. In addition to its medical use, NPP is used to improve physique and performance.